vs
Side-by-side financial comparison of QUICKLOGIC Corp (QUIK) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Relay Therapeutics, Inc. is the larger business by last-quarter revenue ($7.0M vs $5.7M, roughly 1.2× QUICKLOGIC Corp). QUICKLOGIC Corp produced more free cash flow last quarter ($-1.2M vs $-235.9M).
QuickLogic Corp is a fabless semiconductor company developing low-power customizable FPGAs, embedded FPGA IP, and edge sensor processing solutions. Its offerings serve global wearables, IoT, mobile electronics, and industrial markets, enabling energy-efficient low-latency on-device processing for edge AI and sensing use cases.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
QUIK vs RLAY — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.7M | $7.0M |
| Net Profit | $-305.0K | — |
| Gross Margin | 62.7% | — |
| Operating Margin | 2.6% | — |
| Net Margin | -5.4% | — |
| Revenue YoY | -24.1% | — |
| Net Profit YoY | -114.9% | — |
| EPS (diluted) | $-0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $7.0M | ||
| Q3 25 | — | $0 | ||
| Q1 25 | — | $7.7M | ||
| Q4 24 | $5.7M | $0 | ||
| Q3 24 | $4.2M | $0 | ||
| Q2 24 | $4.1M | $0 | ||
| Q1 24 | $5.7M | $10.0M | ||
| Q4 23 | $6.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-74.1M | ||
| Q1 25 | — | $-77.1M | ||
| Q4 24 | $-305.0K | — | ||
| Q3 24 | $-2.1M | $-88.1M | ||
| Q2 24 | $-1.6M | $-92.2M | ||
| Q1 24 | $108.0K | $-81.4M | ||
| Q4 23 | $1.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 62.7% | — | ||
| Q3 24 | 59.1% | — | ||
| Q2 24 | 54.7% | — | ||
| Q1 24 | 67.1% | — | ||
| Q4 23 | 76.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | -1105.2% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | -38.1% | — | ||
| Q2 24 | -29.3% | — | ||
| Q1 24 | 2.3% | -903.0% | ||
| Q4 23 | 19.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | -1003.6% | ||
| Q4 24 | -5.4% | — | ||
| Q3 24 | -49.8% | — | ||
| Q2 24 | -37.8% | — | ||
| Q1 24 | 1.9% | -813.3% | ||
| Q4 23 | 17.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.43 | ||
| Q1 25 | — | $-0.46 | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $-0.14 | $-0.63 | ||
| Q2 24 | $-0.11 | $-0.69 | ||
| Q1 24 | $0.01 | $-0.62 | ||
| Q4 23 | $0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.0M |
| Total DebtLower is stronger | $3.1M | — |
| Stockholders' EquityBook value | $24.9M | $567.1M |
| Total Assets | $51.9M | $621.3M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $91.6M | ||
| Q1 25 | — | $93.5M | ||
| Q4 24 | — | $124.3M | ||
| Q3 24 | — | $152.4M | ||
| Q2 24 | — | $134.1M | ||
| Q1 24 | — | $152.9M | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $1.4M | — | ||
| Q4 23 | — | — |
| Q4 25 | — | $567.1M | ||
| Q3 25 | — | $607.7M | ||
| Q1 25 | — | $721.1M | ||
| Q4 24 | $24.9M | $777.8M | ||
| Q3 24 | $20.9M | $838.9M | ||
| Q2 24 | $21.8M | $681.7M | ||
| Q1 24 | $22.2M | $745.8M | ||
| Q4 23 | $14.0M | — |
| Q4 25 | — | $621.3M | ||
| Q3 25 | — | $670.0M | ||
| Q1 25 | — | $799.4M | ||
| Q4 24 | $51.9M | $871.3M | ||
| Q3 24 | $49.7M | $930.1M | ||
| Q2 24 | $47.5M | $772.5M | ||
| Q1 24 | $51.9M | $841.4M | ||
| Q4 23 | $36.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.12× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | 0.06× | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $116.0K | $-235.5M |
| Free Cash FlowOCF − Capex | $-1.2M | $-235.9M |
| FCF MarginFCF / Revenue | -20.6% | -3370.0% |
| Capex IntensityCapex / Revenue | 22.6% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.4M | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-235.5M | ||
| Q3 25 | — | $-62.1M | ||
| Q1 25 | — | $-73.2M | ||
| Q4 24 | $116.0K | $-249.1M | ||
| Q3 24 | $-16.0K | $-75.1M | ||
| Q2 24 | $-220.0K | $-65.8M | ||
| Q1 24 | $147.0K | $-50.3M | ||
| Q4 23 | $130.0K | — |
| Q4 25 | — | $-235.9M | ||
| Q3 25 | — | $-62.1M | ||
| Q1 25 | — | $-73.6M | ||
| Q4 24 | $-1.2M | $-251.1M | ||
| Q3 24 | $-83.0K | $-75.3M | ||
| Q2 24 | $-4.2M | $-65.8M | ||
| Q1 24 | $62.0K | $-52.1M | ||
| Q4 23 | $-1.5M | — |
| Q4 25 | — | -3370.0% | ||
| Q3 25 | — | — | ||
| Q1 25 | — | -958.4% | ||
| Q4 24 | -20.6% | — | ||
| Q3 24 | -2.0% | — | ||
| Q2 24 | -102.2% | — | ||
| Q1 24 | 1.1% | -520.7% | ||
| Q4 23 | -22.7% | — |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | — | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 1.5% | 17.8% | ||
| Q4 23 | 24.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — | ||
| Q4 23 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
QUIK
| North America | $3.0M | 53% |
| Other | $2.7M | 47% |
RLAY
Segment breakdown not available.
